Hodgkin disease lymphoma
Clinical trials for Hodgkin disease lymphoma explained in plain language.
Never miss a new study
Get alerted when new Hodgkin disease lymphoma trials appear
Sign up with your email to follow new studies for Hodgkin disease lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to tackle resistant lymphomas
Disease control Recruiting nowThis phase II trial is testing whether adding the JAK inhibitor ruxolitinib to the immunotherapy drug pembrolizumab is safe and effective for people with relapsed or refractory Hodgkin and non-Hodgkin lymphomas. The study will enroll 53 participants with specific lymphoma subtype…
Matched conditions: HODGKIN DISEASE LYMPHOMA
Phase 2 • Sponsor: Seda S. Tolu • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Proton beams vs. X-Rays: can a pricier radiation spare hearts and prevent second cancers?
Symptom relief Recruiting nowResearchers are studying whether proton therapy is practical on a national scale and whether it reduces late side effects, such as second cancers and heart damage, compared with standard photon radiation. The trial enrolls adults with Hodgkin or non-Hodgkin lymphoma confined to t…
Matched conditions: HODGKIN DISEASE LYMPHOMA
Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC